Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

General Organization of Teaching Hospitals and Institutes (GOTHI)

Cirrhosis

Publication Year

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Study Of Arterial Blood Gases In Different Stages Of Chronic Liver Diseases, Moheb W. Elfaizy, Therese S. Ghatas Nov 2022

Study Of Arterial Blood Gases In Different Stages Of Chronic Liver Diseases, Moheb W. Elfaizy, Therese S. Ghatas

Journal of Medicine in Scientific Research

Background Early detection of arterial gas abnormalities and acid–base disturbances in patients with chronic liver disease is essential to improve prognosis on the basis of pulmonary and liver diseases. The aim of the current study was to detect arterial blood gas changes, acid–base disturbances, and prevalence of hepatopulmonary syndrome (HPS) in different classes of severity of chronic hepatic disease for achieving a higher survival rate. Results Patients with hypoxemia represented 38 (33.6%) cases: three (15.7%) of 19 patients in group A, 16 (33.3%) of 48 patients in group B, 12 (34.2%) of 35 patients in group C, and seven (63.6%) …


The Efficacy Of Argon Plasma Coagulation In The Treatment Of Gastric Antral Vascular Ectasia In Mataria Teaching Hospital, Aisha El-Shimy, El Saied E. Shabaan, Tarek A. Fouad Apr 2018

The Efficacy Of Argon Plasma Coagulation In The Treatment Of Gastric Antral Vascular Ectasia In Mataria Teaching Hospital, Aisha El-Shimy, El Saied E. Shabaan, Tarek A. Fouad

Journal of Medicine in Scientific Research

Background Gastric antral vascular ectasia (GAVE) is characterized by mucosal and submucosal vascular ectasia. It may present with iron-deficiency anemia or gastrointestinal bleeding. Argon plasma coagulation (APC) may be used for treating GAVE. This study aims to evaluate the efficacy and safety of APC in the treatment of GAVE. Patients and methods A total of 30 patients with GAVE and in need of treatment for bleeding or anemia were treated with APC every 2 to 4 weeks until eradication of GAVE or cessation of the patient's initial symptoms. They were then followed up on a monthly basis for recurrence of …